Skip to main content
Premium Trial:

Request an Annual Quote

The Science of Money Laundering

European authorities are scrambling to recover more than €50 million — about $72 million — given to several individuals to fund what turned out to be fake research projects, says Nature News' Quirin Schiermeier. Italian authorities and the European Anti-Fraud Office in Belgium say they are planning to prosecute members of a criminal syndicate that fooled the European Commission into giving them millions of euros for non-existent science projects. The EC has terminated four collaborative projects in information technology and authorities in the UK, France, Greece, Austria, Sweden, Slovenia, and Poland are conducting investigations, Schiermeier says. A representative from the European Anti-Fraud Office says the fraud was conducted in a manner "resembling money laundering." Schiermeier adds, "To make them seem legitimate, grant applications included the names of real scientists, established research institutes and existing companies, he says. But in most cases the alleged project partners were included without their knowing." The EC says it has already recovered €10 million and is going after the rest.

HT: Mike the Mad Biologist

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.